Literature DB >> 34487813

Three dimensions of autophagy in regulating tumor growth: cell survival/death, cell proliferation, and tumor dormancy.

Yongqiang Chen1, Spencer B Gibson2.   

Abstract

Autophagy is an intracellular lysosomal degradation process involved in multiple facets of cancer biology. Various dimensions of autophagy are associated with tumor growth and cancer progression, and here we focus on the dimensions involved in regulation of cell survival/cell death, cell proliferation and tumor dormancy. The first dimension of autophagy supports cell survival under stress within tumors and under certain contexts drives cell death, impacting tumor growth. The second dimension of autophagy promotes proliferation through directly regulating cell cycle or indirectly maintaining metabolism, increasing tumor growth. The third dimension of autophagy facilitates tumor cell dormancy, contributing to cancer treatment resistance and cancer recurrence. The intricate relationship between these three dimensions of autophagy influences the extent of tumor growth and cancer progression. In this review, we summarize the roles of the three dimensions of autophagy in tumor growth and cancer progression, and discuss unanswered questions in these fields.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autophagy; Cell death; Cell survival; Proliferation; Tumor dormacy; Tumor growth

Mesh:

Year:  2021        PMID: 34487813     DOI: 10.1016/j.bbadis.2021.166265

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  3 in total

1.  Resveratrol Contrasts IL-6 Pro-Growth Effects and Promotes Autophagy-Mediated Cancer Cell Dormancy in 3D Ovarian Cancer: Role of miR-1305 and of Its Target ARH-I.

Authors:  Andrea Esposito; Alessandra Ferraresi; Amreen Salwa; Chiara Vidoni; Danny N Dhanasekaran; Ciro Isidoro
Journal:  Cancers (Basel)       Date:  2022-04-25       Impact factor: 6.575

2.  Tumor Suppressing Subtransferable Candidate 4 Expression Prevents Autophagy-Induced Cell Death Following Temozolomide Treatment in Glioblastoma Cells.

Authors:  Yongqiang Chen; Spencer B Gibson
Journal:  Front Cell Dev Biol       Date:  2022-03-02

Review 3.  Mini-Review: Can the Metastatic Cascade Be Inhibited by Targeting CD147/EMMPRIN to Prevent Tumor Recurrence?

Authors:  Michal A Rahat
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.